» Articles » PMID: 39770302

Contribution of Magnetic Resonance Imaging Studies to the Understanding of Cerebral Malaria Pathogenesis

Overview
Journal Pathogens
Date 2025 Jan 8
PMID 39770302
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral malaria (CM), the most lethal clinical syndrome of infection, mostly affects children under 5 in sub-Saharan Africa. CM is characterized by seizures and impaired consciousness that lead to death in 15-20% of cases if treated quickly, but it is completely fatal when untreated. Brain magnetic resonance imaging (MRI) is an invaluable source of information on the pathophysiology of brain damage, but, due to limited access to scanners in endemic regions, only until very recently have case reports of CM patients studied with advanced MRI methods been published. The murine model of experimental cerebral malaria (ECM) shares many common features with the human disease and has been extensively used to study the pathogenic mechanisms of the neurological syndrome. In vivo MRI studies on this model, the first of which was published in 2005, have contributed to a better understanding of brain lesion formation in CM and identified disease markers that were confirmed by MRI studies published from 2013 onwards in pediatric patients from endemic areas. In this review, we recapitulate the main findings and critically discuss the contributions of MRI studies in the ECM model to the understanding of human CM.

References
1.
Morrell C, Aggrey A, Chapman L, Modjeski K . Emerging roles for platelets as immune and inflammatory cells. Blood. 2014; 123(18):2759-67. PMC: 4007605. DOI: 10.1182/blood-2013-11-462432. View

2.
Sousa A, Milheiro Silva T, Conceicao C, Vieira J, Gouveia C, Varandas L . Cerebral Malaria and Cytotoxic Lesions of the Corpus Callosum. Pediatr Infect Dis J. 2023; 42(9):e358-e359. DOI: 10.1097/INF.0000000000003963. View

3.
Idro R, Jenkins N, Newton C . Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005; 4(12):827-40. DOI: 10.1016/S1474-4422(05)70247-7. View

4.
Varo R, Crowley V, Sitoe A, Madrid L, Serghides L, Kain K . Adjunctive therapy for severe malaria: a review and critical appraisal. Malar J. 2018; 17(1):47. PMC: 5781278. DOI: 10.1186/s12936-018-2195-7. View

5.
Mohanty S, Mishra S, Patnaik R, Dutt A, Pradhan S, Das B . Brain swelling and mannitol therapy in adult cerebral malaria: a randomized trial. Clin Infect Dis. 2011; 53(4):349-55. PMC: 3148260. DOI: 10.1093/cid/cir405. View